Neurology MRI

Images show smaller hippocampal volume in patients with sickle cell disease compared to healthy patients.

Patients experience fewer neurologic, motor, and language problems post-surgery.

Study shows lower energy reserve index in patients with mild cognitive impairment and early Alzheimer’s.

Real-time visualization of brain movement can help radiologists identify hard-to-detect brain conditions.

Adding 18F-FET PET to contrast-enhanced MRI can better determine which patients are responding well to immune checkpoint inhibitors or targeted therapies.

Diffusion-prepared arterial spin labeling can measure the water exchange rate across the blood-brain barrier, catching malfunctions at an earlier state.

7T MRI highlighted multiple hippocampus differentiations between individuals with DS and healthy study participants.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Scans show significant similarities between gray and white brain matter changes in patients with both conditions.

What is your diagnosis in this 68-year-old man with increasing memory loss and dementia?

Using a model trained on three data sets could lead to automated categorization of “likely normal” and “likely abnormal” brain MRI results.

The diagnostic performance for central precocious puberty, growth hormone deficiency, and short stature is similar to that of standard contrast protocols.

Study finds clinically significant percentage of patients with metastatic renal cell carcinoma develop asymptomatic brain metastases.

In a young patient with chronic seizures, what is the diagnosis?

In patients with cerebral small vessel disease, brain tissue damage can occur before lesions even appear on imaging.

While most cases do not point to an urgent need, knowing how frequently these findings appear can help with decision-making.

Here's what to expect this week on Diagnostic Imaging.

Study shows conducting MRI scans earlier in patients with mild TBI could identify which patients are likely to have the worse outcomes and when more timely intervention is necessary.

Pairing these scans with biological and clinical data can help providers with diagnosis and potential treatment.

This correlation can help providers pinpoint which patients will develop more neurological abnormalities, helping them plan interventions to improve outcomes.

Advancements in reducing field strength are bringing MRI closer to populations unserved by the technology.

Patients receiving standard therapy and intensive therapy for high blood pressure revealed no significant biomarker differences for Alzheimer’s disease on brain images.

Here's what to expect this week on Diagnostic Imaging.

Compared with three other methods, shear wave elastography providers greater sensitivity in pinpointing remaining malignant tissue after brain tumor removal.

Images reveal ultrasound therapy can effectively open and close the blood-brain barrier, opening the door for potential new Alzheimer’s treatments.

CT Colonography & Tumor Differentiation; COVID-19 & Leukoencephalopathy; MRI, the Angiography Suite, and Acute Ischemic Stroke; Plus, DBT, African American Women, & Decreased Access

Using MRI in the angiography suite can help providers decide whether to continue with thrombectomy, to place stents, or to administer anti-thrombotic medications.

Images can show indications of rare condition that can affect white brain matter in patients who test positive for the virus.

Here's what to expect this week on Diagnostic Imaging.

First brain MRI findings reveal dangerous COVID-19-related optical findings.